Physician profile
Yuli Wang
NPI 1801242581
$15,276.13
in general payments reported to CMS, 2019-2025
33 companies · $3,851 in 2025
The $3,851 reported for 2025 was more than what 98% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,365 · 2022: $2,204 · 2023: $3,893 · 2024: $3,963 · 2025: $3,851.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $11K · Education: $352.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $11,355.57 |
| Education | $351.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,758.47 | 2021-2025 | |
| Incyte Corporation | $1,538.22 | 2021-2025 | Opzelura, Opzelura |
| Genzyme Corporation | $1,529.01 | 2021-2025 | |
| Regeneron Healthcare Solutions, INC. | $1,415.72 | 2021-2025 | Dupixent, Libtayo |
| Sun Pharmaceutical Industries INC. | $1,253.37 | 2021-2025 | Absorica Ld, Winlevi, Ilumya |
| E.R. Squibb & Sons, L.L.C. | $1,058.28 | 2022-2024 | Sotyktu |
| Galderma Laboratories, L.P. | $626.29 | 2021-2025 | Nemluvio, Dysport |
| Leo Pharma INC. | $613.35 | 2021-2025 | Adbry, Anzupgo |
| Strata Skin Sciences, INC. | $518.94 | 2022-2025 | Xtrac |
| Ucb, INC. | $403.25 | 2021-2025 | Bimzelx |
| Janssen Biotech, INC. | $380.65 | 2021-2025 | Tremfya, Simponi Aria, Simponi |
| Amgen INC. | $376.53 | 2021-2025 | Otezla, Otezla |
| Lilly USA, LLC | $369.88 | 2022-2025 | Taltz, Ebglyss, Olumiant |
| Arcutis Biotherapeutics, INC. | $337.94 | 2023-2025 | Zoryve |
| Journey Medical Corporation | $305.11 | 2022-2025 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $275.29 | 2021-2025 | |
| Mayne Pharma Commercial LLC | $261.14 | 2021-2025 | |
| Pfizer INC. | $231.27 | 2021-2025 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $160.41 | 2023-2024 | Siliq, Duobrii |
| Almirall LLC | $147.90 | 2021-2024 | Seysara |
| Cipher Pharmaceuticals US LLC | $122.42 | 2025 | Spinosad, Natroba |
| Trisalus Life Sciences, INC. | $99.49 | 2023 | Trinav Infusion System |
| Vyne Pharmaceuticals INC. | $77.74 | 2021 | |
| Dermavant Sciences, INC. | $69.09 | 2022-2024 | Vtama |
| Verrica Pharmaceuticals INC. | $61.66 | 2024-2025 | Ycanth |
| Janssen Scientific Affairs, LLC | $60.00 | 2022 | |
| Merz North America, INC. | $55.88 | 2022-2025 | |
| Biofrontera INC. | $44.55 | 2023-2025 | Ameluz, Xepi, Bf-Rhodoled |
| Dermira, INC. | $43.90 | 2021 | |
| Epi Health, LLC | $34.12 | 2021 | |
| Botanix Sb INC | $22.80 | 2025 | Sofdra |
| Phadia US INC. | $19.66 | 2021 | |
| Organon LLC | $3.80 | 2025 | Vtama |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yuli Wang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.